Literature DB >> 32900596

The Sex Bias of Cancer.

Ana Raquel Costa1, Mariana Lança de Oliveira1, Inês Cruz1, Isabel Gonçalves1, José Francisco Cascalheira2, Cecília R A Santos3.   

Abstract

In hormone-dependent organs, sex hormones and dysregulated hormone signaling have well-documented roles in cancers of the breast and female reproductive organs including endometrium and ovary, as well as in prostate and testicular cancers in males. Strikingly, epidemiological data highlight significant differences between the sexes in the incidence of various cancers in nonreproductive organs, where the role of sex hormones has been less well studied. In an era when personalized medicine is gaining recognition, understanding the molecular, cellular, and biological differences between men and women is timely for developing more appropriate therapeutic interventions according to gender. We review evidence that sex hormones also shape many of the dysregulated cellular and molecular pathways that lead to cell proliferation and cancer in nonreproductive organs.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  bladder cancer; gastrointestinal cancer; glioblastoma; sex hormone; thyroid cancer

Mesh:

Substances:

Year:  2020        PMID: 32900596     DOI: 10.1016/j.tem.2020.07.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  6 in total

Review 1.  Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades.

Authors:  Sara Napoli; Nicolas Munz; Francesca Guidetti; Francesco Bertoni
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

Review 2.  Roles of enhancer RNAs in sex hormone-dependent cancers.

Authors:  Lu Zhang; Xiaoxia Ye; Jieyi Luo; Jiayu Chen; Weirang Zheng; Minhua Wu
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-22       Impact factor: 4.553

Review 3.  Sexual Dimorphism in Colon Cancer.

Authors:  Maria Abancens; Viviana Bustos; Harry Harvey; Jean McBryan; Brian J Harvey
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

4.  Impact of Androgen Suppression Therapy on the Risk and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis.

Authors:  Peng Xiang; Zhen Du; Yongxiu Hao; Di Guan; Dan Liu; Wei Yan; Mingdong Wang; Yutong Liu; Hao Ping
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

5.  Ultrasonic Characteristics Improve Prediction of Central Lymph Node Metastasis in cN0 Unifocal Papillary Thyroid Cancer.

Authors:  Yongchen Liu; Jianhao Huang; Zhiyuan Zhang; Yijie Huang; Jialin Du; Sanming Wang; Zeyu Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-20       Impact factor: 6.055

6.  Burden of brain and other central nervous system cancer in China, 1990-2019: a systematic analysis of observational data from the global burden of disease study 2019.

Authors:  Xinran Hou; Zongbin Song; Fan Zhang; Zhuoyi Liu; Wenyong Long; Zheng Long; Maigeng Zhou; E Wang; Peng Yin; Maoen Zhu
Journal:  BMJ Open       Date:  2022-07-18       Impact factor: 3.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.